Cromos Pharma supporting Breast Cancer Awareness Month

October is Breast Cancer Awareness Month, where people all over the world highlight the seriousness of this condition, promote awareness of the importance of early detection and diagnosis, as well as showing their support for patients affected by breast cancer. It serves as a reminder that in spite of recent advances in treatments, efforts must continue to find ways to detect and treat this condition to save and improve the lives of millions of people around the globe. Cromos Pharma is committed to supporting treatment breakthroughs and wholeheartedly supports efforts to raise awareness of breast cancer.


Cromos Pharma making sure your clinical trial is feasible

It is estimated that up to 80% of clinical studies fail to recruit sufficient numbers of participants. These failures waste valuable resources and time as well as delaying new treatments reaching patients. At Cromos Pharma we understand how important it is to conduct robust feasibility assessments of clinical trials to optimize the chances of success. That's why we have developed our Free Feasibility Reports initiative to assist sponsors considering expanding their clinical trials into Central and Eastern Europe. 

Cromos Pharma supporting clinical research to beat heart disease

World Heart Day is Wednesday, 29th September. It is a day to raise awareness about the importance of your heart and ways to keep your heart healthy – no matter what age you are. It is also a day to recognize the incredible achievements in clinical research that have helped develop innovative therapies and treatments to improve the lives of patients with heart disease. Cromos Pharma is proud to play its part in supporting clinical research to make breakthroughs in the treatment of heart disease.


Conducting clinical trials in the Czech Republic with Cromos Pharma

Cromos Pharma has been managing clinical trials in the Czech Republic since the 2010s and established a permanent office in its capital Prague in 2015. Czechia is recognized as an attractive location for international clinical trials with a strong track record for producing high-quality data and lengthy experience in Good Clinical Practices provided by the ICH-GCP. 

Cromos Pharma supporting Blood Cancer Awareness Month

September is Blood Cancer Awareness MonthApproximately 1.24 million blood cancer cases occur annually worldwide, accounting for almost 6% of all cancer cases. In the US, blood cancers are the third leading cause of cancer deaths yet the impact of these cancers is under recognized. Despite recent progress in blood cancer research, more than 1/3 of blood cancer patients still do not survive five years after diagnosis. This September, Cromos Pharma is pleased to raise awareness of blood cancers and reaffirm its commitment to supporting clinical research to make treatment breakthroughs.



Cromos Pharma successfully completes enrollment for a Phase II COVID-19 vaccine clinical trial

Cromos Pharma today (Thursday, 16 September, 2021) announced that it has successfully completed recruitment for a Phase II COVID-19 vaccine clinical trial. 
See more